Resistance to antiretroviral drugs
Calvez, V.
Antiviral Therapy 3 Suppl. 4: 5-7
1998
ISSN/ISBN: 1359-6535 PMID: 10723502 Document Number: 485212
There are many questions regarding testing for viral resistance to antiretroviral drugs and interpretation of test results. The most appropriate time for testing and the compartment from which to derive virus are still uncertain. Both phenotypic and genotypic tests are used to measure drug susceptibility; however, interpretation of results of these assessments is not clear-cut. Furthermore, correlation of these test results with clinical outcome or pharmacological data is limited by lack of studies and other confounding factors.
Document emailed within 1 workday
Related Documents
Rosina, M. 2001: Resistance to antiretroviral drugs Recenti Progressi in Medicina 92(9): 546-551Gómez-Cano, M.; Soriano, V. 1997: Resistance to antiretroviral drugs Medicina Clinica 109(14): 546-548
Hamers, R.L.; Derdelinckx, I.; van Vugt, M.èl.; Stevens, W.; Rinke de Wit, T.F.; Schuurman, R. 2008: The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa Antiviral Therapy 13(5): 625-639
Hamers, R.L.; Derdelinckx, I.; van Vugt, M.èl.; Stevens, W.; Rinke de Wit, T.F.; Schuurman, R. 2008: The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa Antiviral Therapy 13(5): 625-639
Vergne, L.; Malonga-Mouellet, G.; Mistoul, I.; Mavoungou, R.; Mansaray, H.; Peeters, M.; Delaporte, E. 2002: Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries Journal of Acquired Immune Deficiency Syndromes 29(2): 165-168
Vergne, L.; Malonga-Mouellet, G.; Mistoul, I.; Mavoungou, R.; Mansaray, H.; Peeters, M.; Delaporte, E. 2002: Resistance to antiretroviral treatment in Gabon: need for implementation of guidelines on antiretroviral therapy use and HIV-1 drug resistance monitoring in developing countries Journal of Acquired Immune Deficiency Syndromes 29(2): 165-168
Zapiola, I.és.; Cecchini, D.; Fernández Giuliano, S.; Martínez, M.; Rodríguez, C.; Bouzas, M.ía.B.én. 2016: HIV-1 resistance to antiretroviral drugs in pregnant women from Buenos Aires metropolitan area Medicina 76(6): 349-354
Castelbranco, E.P.íc.A.é F.él.; da Silva Souza, E.; Cavalcanti, A.M.S.; Martins, A.él.N.; de Alencar, L.C.úd.A.; Tanuri, A. 2010: Frequency of primary resistance to antiretroviral drugs and genetic variability of HIV-1 among infected pregnant women recently diagnosed in Luanda-Angola Aids Research and Human Retroviruses 26(12): 1313-1316
Gupta, R.K.; Wainberg, M.A.; Brun-Vezinet, F.; Gatell, J.M.; Albert, J.; Sönnerborg, A.; Nachega, J.B. 2013: Oral antiretroviral drugs as public health tools for HIV prevention: global implications for adherence, drug resistance, and the success of HIV treatment programs Journal of Infectious Diseases 207 Suppl. 2: S101-S106
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Baesi, K.; Ravanshad, M.; Ghanbarisafari, M.; Saberfar, E.; Seyedalinaghi, S.; Volk, J.E. 2014: Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran Journal of Medical Virology 86(7): 1093-1098
Corzillius, M.; Mühlberger, N.; Sroczynski, G.; Jaeger, H.; Wasem, J.ür.; Siebert, U. 2004: Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV Antiviral Therapy 9(1): 27-36
Hamers, R.L.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Conradie, F.; Botes, M.E.; Wellington, M.; Osibogun, A.; Sigaloff, K.C.E.; Nankya, I.; Schuurman, R.; Wit, F.W.; Stevens, W.S.; van Vugt, Mèle.; de Wit, T.F.Rinke.; Mandaliya, K.; Abdallah, S.; Jao, I.; Dolan, M.; Schuurman, R.; Wensing, A.M.; Hamers, R.L.; Sigaloff, K.C.E.; Straatsma, E.; Wit, F.W.; van Vugt, M.; Lange, J.M.; Rinke de Wit, T.F.; Osibogun, A.; Akanmu, S.; Botes, M.E.; Conradie, F.; Ive, P.; Sanne, I.; Wallis, C.L.; Letsoalo, E.; Stevens, W.S.; Hardman, M.; Kityo, C.; Namayanja, G.; Nakatudde, L.; Nankya, I.; Kiconco, M.; Abwola, M.; Mugyenyi, P.; Ndembi, N.; Lyagoba, F.; Kaleebu 2011: HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study Lancet. Infectious Diseases 11(10): 750-759
Diouf, A.; Youbong, T.J.; Maynart, M.; Ndoye, M.; Diéye, F.L.; Ndiaye, N.A.; Koita-Fall, M.B.; Ndiaye, B.; Seydi, M. 2017: Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription Revue d'Epidemiologie et de Sante Publique 65(4): 295-300
Newman, H.; Breunig, L.; van Zyl, G.; Stich, A.; Preiser, W. 2014: A qualitative PCR minipool strategy to screen for virologic failure and antiretroviral drug resistance in South African patients on first-line antiretroviral therapy Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 60(4): 387-391
Wendo, C. 2003: Africans advocate antiretroviral strategy similar to DOTS. AIDS experts suggest community health workers should help in the delivery of antiretroviral drugs Lancet 362(9391): 1210
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Idemyor, V. 2001: HIV resistance and tolerability issues in antiretroviral therapy Journal of the National Medical Association 93(4): 151-153
Richman, D.D. 2012: Antiretroviral drug resistance in resource-limited settings Lancet 380(9849): 1210-1211